Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Merck reveals progress in obesity/diabetes program at ACS meeting

March 24, 1999

ACS highlights: novel guanylureas as NPY Y1 antagonists presented by Alanex

March 24, 1999

Highly potent and selective sst2 receptor agonist: discovery and synthesis discussed at ACS meeting

March 24, 1999

Fluvastatin lowers LDL, raises HDL cholesterol

March 24, 1999

Romozin cannot be reintroduced in the U.K., MCA says

March 23, 1999

Lilly reports initial clinical data for LY-333531

March 23, 1999

New dosage strength and expanded indications approved for Climara

March 23, 1999

SD/01, a pegylated form of filgrastim with superior pharmacokinetics

March 23, 1999

Ergo Science intends to appeal FDA decision on Ergoset

March 23, 1999

Cholesterol biosynthesis inhibitors in the Zeneca pipeline

March 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...